ID: h-debate-4e334c6b214c
Hypothesis

Microglial SPM Receptor Priming Therapy

Chronic pre-treatment with low-dose SPM receptor agonists could prime microglial resolution machinery before neurodegeneration onset, creating a neuroprotective state.
🧬 FPR2, GPR32, GPR18🎯 Composite 0%💱 $0.51▲1.1%proposed
neurodegeneration
EvidenceModerate (50%)📖 0 cit🗣 1 debates 1 support 0 oppose
✓ All Quality Gates Passed
Mechanistic 0.60 (15%) Evidence 0.55 (15%) Novelty 0.60 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.000 composite

🧪 Overview

Chronic pre-treatment with low-dose SPM receptor agonists could prime microglial resolution machinery before neurodegeneration onset, creating a neuroprotective state. This would involve upregulating ALX/FPR2, GPR32, and other SPM receptors.

Debate provenance: derived from debate `sess_sda-2026-04-01-gap-014` on question: SPMs (resolvins, protectins, maresins) from omega-3s may promote inflammation resolution. Are resolution failures druggable?. Consensus signal: domain_expert, skeptic, synthesizer, theorist discussed the mechanism terms ALX/FPR2, FPR2, GPR18, GPR32, Microglial, Priming, Receptor, SPM. Novelty signal: skeptic-discussed-with-qualified-concession.

🧬 Mechanism

🔗 Mechanism from KG for FPR2, GPR32, GPR18

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    TFRC["TFRC"] -->|encodes| transferrin_receptor["transferrin_receptor"]
    transferrin_receptor_1["transferrin_receptor"] -->|mediates| blood_brain_barrier_trans["blood_brain_barrier_transport"]
    CMKLR1["CMKLR1"] -->|encodes| GPR32["GPR32"]
    GPR32_2["GPR32"] -->|regulates| microglial_efferocytosis["microglial_efferocytosis"]
    microglial_efferocytosis_3["microglial_efferocytosis"] -->|resolves| neuroinflammation["neuroinflammation"]
    BCL2L1["BCL2L1"] -->|encodes| BCL_xL["BCL-xL"]
    BCL_xL_4["BCL-xL"] -->|promotes| senescent_cell_survival["senescent_cell_survival"]
    ALOX12["ALOX12"] -->|encodes| n12_lipoxygenase["12-lipoxygenase"]
    n12_lipoxygenase_5["12-lipoxygenase"] -->|catalyzes| maresin_biosynthesis["maresin_biosynthesis"]
    ALOX15["ALOX15"] -->|encodes| n15_lipoxygenase["15-lipoxygenase"]
    n15_lipoxygenase_6["15-lipoxygenase"] -->|catalyzes| lipoxin_A4_synthesis["lipoxin_A4_synthesis"]
    lipoxin_A4_synthesis_7["lipoxin_A4_synthesis"] -->|regulates| astrocyte_polarization["astrocyte_polarization"]
    style TFRC fill:#ce93d8,stroke:#333,color:#000
    style transferrin_receptor fill:#4fc3f7,stroke:#333,color:#000
    style transferrin_receptor_1 fill:#4fc3f7,stroke:#333,color:#000
    style blood_brain_barrier_trans fill:#81c784,stroke:#333,color:#000
    style CMKLR1 fill:#ce93d8,stroke:#333,color:#000
    style GPR32 fill:#4fc3f7,stroke:#333,color:#000
    style GPR32_2 fill:#4fc3f7,stroke:#333,color:#000
    style microglial_efferocytosis fill:#81c784,stroke:#333,color:#000
    style microglial_efferocytosis_3 fill:#81c784,stroke:#333,color:#000
    style neuroinflammation fill:#ef5350,stroke:#333,color:#000
    style BCL2L1 fill:#ce93d8,stroke:#333,color:#000
    style BCL_xL fill:#4fc3f7,stroke:#333,color:#000
    style BCL_xL_4 fill:#4fc3f7,stroke:#333,color:#000
    style senescent_cell_survival fill:#81c784,stroke:#333,color:#000
    style ALOX12 fill:#ce93d8,stroke:#333,color:#000
    style n12_lipoxygenase fill:#4fc3f7,stroke:#333,color:#000
    style n12_lipoxygenase_5 fill:#4fc3f7,stroke:#333,color:#000
    style maresin_biosynthesis fill:#81c784,stroke:#333,color:#000
    style ALOX15 fill:#ce93d8,stroke:#333,color:#000
    style n15_lipoxygenase fill:#4fc3f7,stroke:#333,color:#000
    style n15_lipoxygenase_6 fill:#4fc3f7,stroke:#333,color:#000
    style lipoxin_A4_synthesis fill:#81c784,stroke:#333,color:#000
    style lipoxin_A4_synthesis_7 fill:#81c784,stroke:#333,color:#000
    style astrocyte_polarization fill:#81c784,stroke:#333,color:#000

⚖️ Evidence

📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — FPR2

No curated PDB or AlphaFold mapping for FPR2 yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for FPR2, GPR32, GPR18 →

No DepMap CRISPR Chronos data found for FPR2, GPR32, GPR18.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0002
Events (7d)
1
Price History
▲1.1%

💾 Resource Usage

LLM Tokens
15,342
$0.0921
Total Cost
$0.0921
Metadatasource: v1_phase_c_backfill · origin_type: debate_round_mining
sourcev1_phase_c_backfill
origin_typedebate_round_mining
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.